| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |